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In 1999 a model was published for prediction of growth in
children with idiopathic GH deficiency (IGHD) during GH
therapy, derived using data from the Kabi Pharmacia Inter-
national Growth Study (KIGS) database (Pharmacia & Up-
john, Inc., International Growth Database). We validated and
calibrated this KIGS model for growth in the first year of GH
therapy using data from 136 Dutch children with IGHD. Ob-
served vs. predicted outcomes were plotted, and the fitted
regression line was significantly different from the line of
identity (P  0.03). It appeared that the predictions were too
extreme: relatively low predictions were too low, relatively
high predictions were too high. This is a well known phenom-
enon in the context of prediction models, called overoptimism.
For valid application to other data the KIGS predictions
should be calibrated. Calibrated predictions are obtained us-
ing Ycal  Yorig  (2.153  0.192  Yorig), where Ycal is the
calibrated prediction, and Yorig is the KIGS prediction. The
calibrated prediction will be higher than the original KIGS
prediction when the original prediction is less than 11.2 cm/yr
and will be lower otherwise. The variability of the prediction
errors of the calibrated predictions was positively related to
the value of the prediction (P < 0.001), described by the equa-
tion SDpred err1.017 0.286Ycal. Our calibrated model will
give better predictions for children with IGHD fulfilling the
same criteria. (J Clin Endocrinol Metab 88: 1223–1227, 2003)
BECAUSE OF THE variability of response to GH treat-ment during the last decade several prediction models
have been developed (1–4). It is well known that prediction
models often perform less well than expected when applied
to new patients, either of the same population or other pop-
ulations. According to recent statistical insights this is in
many instances due to the problem of overoptimism, which
results in predictions that are too extreme (5, 6). This over-
optimism, also called overfitting, is more pronounced if the
prediction model is developed by selecting the predictor
variables from a group of possible candidate predictors, and
this selection is determined by the data. If a representative
dataset is used, and a proper modeling method is applied,
there is practically no doubt that in the final model the
selected variables will be related to the outcome in that as
well as in other datasets fulfilling the same criteria. However,
the selection of exactly these predictor variables and exactly
these values of the estimated coefficients of the predictors
will partly be determined by the accidental characteristics of
the dataset. This will give a model that is too much data-
driven and will differentiate the subjects in predicted out-
come too extremely. Even apart from this effect of variable
selection, overfitting is likely to occur in each prediction
model with two or more prediction variables (7). For valid
application of a prediction model to new patients the pre-
dictions should therefore be calibrated by shrinking them to
less extreme values.
In this study we used data from Dutch children with
idiopathic GH deficiency (IGHD) to validate the prediction
model derived on the database of the Kabi Pharmacia In-
ternational Growth Study (KIGS; Pharmacia & Upjohn, Inc.,
International Growth Database) (8) for growth velocity of
children with IGHD during the first year of GH therapy (2).
This model, further referred to as the KIGS model, was de-
veloped on a dataset containing data from 593 children and
is widely used in clinical practice. A validation of the model,
using data from subsequent children from the KIGS database
(temporal validation) as well as data from other studies (ex-
ternal validation), was described previously (2). Our study
validated the model on a large external dataset with special
attention to the problem of overfitting.
Patients and Methods
Patients
For validation of the model we used data from the database of the
Dutch Growth Foundation, containing data for all Dutch children who
have been or are being treated with GH. We applied the same inclusion
and exclusion criteria as were used for the cohort from which the KIGS
model for children with IGHD was derived, although other brands of
biosynthetic GH than Genotropin (Pharmacia & Upjohn Inc., Stockholm,
Sweden) were used also. Height measurements for calculation of first
year height velocity (HV) were allowed to have been performed between
0.8–1.25 yr after the start of treatment, comparable with the validation
described in the paper in which the KIGS model was presented (2).
Observed and predicted outcomes
HV was computed correcting for the time interval between the start
of treatment and the actual date of the height measurement after 1 yr of
treatment. For the predictors used in the model, the sd scores were
computed with the same reference data as those used for the KIGS cohort
(9–11). The KIGS prediction was computed using the regression equa-
Abbreviations: HV, Height velocity; IGHD, idiopathic GH deficiency;
PI, prediction interval.
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tion based on data at the start of treatment: predicted HV (cm/yr) 
14.55  1.37  maximum GH response (ln; micrograms per liter) 
0.32  age (yr)  0.32  birth weight sd score  1.62  GH dose (ln;
international units per kilogram per week)  0.40  (height sd score 
midparental height sd score)  0.29  weight sd score.
Statistical analysis
For the validation, we followed the method described by Van Hou-
welingen (12). The observed HV was plotted vs. the predicted HV in a
calibration plot. A regression analysis was performed with observed HV
as the outcome and predicted HV as the determinant, and it was tested
whether the regression line was significantly different from the line of
identity (where observed HV is equal to predicted HV). The estimated
coefficients from the regression analysis were then used to determine the
calibration correction. Using the calibrated predictions, we tested the
homogeneity of variance of the prediction errors using the Spearman
rank correlation between the absolute values of the prediction errors and
the values of the predictions (13). In case of a significant correlation, the
relation was modeled (14). In searching for the regression model for
absolute residuals depending on predicted values, we allowed for frac-
tional polynomials (15).
Results
One hundred and thirty-six cases of the Dutch database
fulfilled the inclusion and exclusion criteria. The character-
istics of this Dutch cohort were well within the ranges of the
KIGS cohort (Table 1). The prediction errors (observed HV
minus predicted HV) had a mean of 0.25 cm/yr and an sd
of 1.95 cm/yr. The observed vs. predicted values are plotted
in Fig. 1 together with the line of identity (where observed
HV is equal to predicted HV; dotted line) and the fitted re-
gression line. The figure shows that relatively low predic-
tions tended to be underestimated, and relatively high pre-
dictions tended to be overestimated. The deviation of the
regression line from the line of identity was statistically sig-
nificant (P 0.03), and the estimated slope was 0.808. To get
a fitted regression line with a slope of 1 (line of identity),
which is preferred, points at the left, relatively low predic-
tions, should be shifted a little to the right, and points at the
right, relatively high predictions, should be shifted a little to
the left. This calibration correction is described by the
formula:
Ycal Yorig 2.153 0.192  Yorig
where Ycal is the calibrated prediction, and Yorig is the orig-
inal KIGS prediction.
The correction term, (2.153  0.192  Yorig), has a positive
value for predictions below 11.2 cm/yr (point of intersection
of the regression line and the line of identity) and a negative
value for predictions above 11.2 cm/yr.
Using the calibrated model the prediction errors had a
mean of zero and an sd of 1.91 cm/yr. When prediction errors
were plotted vs. calibrated predictions (Fig. 2), an increase in
variance of the prediction errors was seen with increasing
value of the prediction. The absolute values of the prediction
errors turned out to be positively related to the value of the
predictions (P  0.001). The relation between the calibrated
predictions and the variability of their prediction errors was
described with the model:
SDpred error1.017 0.286  Ycal
The differences between the predictions of the original
KIGS model and the calibrated model are illustrated by two
examples (Table 2). Example 1 shows that for a child with a
relatively low prediction (predicted HV using the KIGS
model, 7.0 cm/yr), the calibrated prediction is higher
(7.8 cm/yr), whereas the 95% prediction interval (PI) is
smaller than the PI using the KIGS model. Example 2 dem-
onstrates that a relatively high prediction decreases after
FIG. 1. First year HV (centimeters per year): observed vs. KIGS pre-
dicted values, together with the line of identity (dotted) and the fitted
regression line (solid).
TABLE 1. Characteristics of children with IGHD from the KIGS cohort and the Dutch cohort
KIGS cohort Dutch cohort
Mean Min Max Mean Min Max
Age (yr) 7.3 2.1 11.9 6.8 2.0 11.9
Height SD score 2.6 5.4 0.4 2.1 5.3 0.3
Weight SD score 2.2 3.8 0.7 1.9 4.6 0.8
MPH SD score 0.6 3.4 2.3 0.4 2.1 3.4
Height SD score  MPH SD score 1.9 6.2 1.7 2.5 6.6 0.0
BW SD score 0.5 2.0 3.6 0.3 1.9 3.1
Max GH-peak (g/liter) 5.6 0.3 10.0 5.2 0.5 10.0
GH dose (IU/kgwk) 0.6 0.2 1.3 0.6 0.3 1.3
HV in first year (cm/yr) 9.2 3.5 16.8 10.2 5.4 17.4
MPH, Midparental height; BW, birth weight.
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calibration (KIGS prediction, 14.0 cm/yr; calibrated predic-
tion, 13.5 cm/yr), whereas the 95% PI becomes much wider.
For the calculation of sd scores of the auxological charac-
teristics used in the KIGS model, United Kingdom reference
data (9, 10) were used. When for our validation in the Dutch
cohort, national reference data were used [namely for height
and weight at the start of treatment, the reference data from
the 1997 study by Fredriks et al. (16) and for height of the
parents the reference data from the 1965 study by Van
Wieringen et al. (17)], the mean of the prediction errors was
0.23 cm/yr. The overfitting was again significant (P 0.001),
and the estimated slope in the calibration plot was 0.791. If
the 1997 reference data were also used for height of the
parents, the estimated slope was similar, but the mean pre-
diction error increased to 0.60 cm/yr and was significantly
different from zero (P  0.001).
Discussion
In this paper for the first time a validation according to
modern statistical insights into the behavior of prediction
models was applied to a widely used prediction model for
first year response to GH therapy. Special attention was
given to the problem of overfitting. The analysis resulted in
a calibrated model with a better fit when applied to new data.
The method of validation we have used is based on and
illustrated by a calibration plot where observed values are
plotted vs. predicted values, in our case observed HV in the
first year of GH treatment vs. the prediction given by the
KIGS model. Four examples of calibration plots are shown in
Fig. 3. In all figures the line of identity, where the observed
outcome is equal to the predicted outcome, is drawn. Perfect
predictions will all lay on the line of identity (Fig. 3A). If the
predictions are not perfect, but unbiased, the plot will show
points scattered randomly around the line of identity (Fig.
3B). Any other pattern in the calibration plot indicates that
the prediction model does not fit well to the validation data.
As an example, Fig. 3C shows a scatter plot with points too
much on the right side of the line of identity. Because the
vertical position of the points is fixed, determined by the
observed value, the horizontal position should be corrected
by shifting all points a little to the left. This indicates that the
original predictions are, on the average, too high. Another,
frequently occurring pattern is that the scatter plot shows a
relation between the observed and predicted outcomes with
a lower slope than the line of identity (Fig. 3D). Now a
correction should be made by shifting the points at the left
side a little to the right, and the points at the right side a little
to the left. This indicates underestimation of the lowest pre-
dictions and overestimation of the highest predictions. The
model classifies too extremely into good and bad responses,
and therefore this phenomenon is called overfitting or over-
optimism. Overfitting is common when the selection of pre-
dictors and the estimation of their coefficients are both
guided by the same dataset (18, 19). The occurrence of over-
fitting is not the result of differences between the modeling
group and the validation group. Suppose we start with one
dataset and split this randomly into a modeling group and
a validation group, thus without systematic differences be-
tween the two groups. If we develop a prediction model on
the modeling group, applying the model to the validation
group will very likely show overfitting too.
In our validation of the KIGS model the calibration plot
showed a pattern like that in Fig. 3D, although less extreme.
The slope of the regression line was 0.808, and the line was
significantly different from the line of identity. The overfit-
ting could be corrected using the formula: Ycal  Yorig 
(2.153  0.192  Yorig). This leads to a correction of the
predictions from the KIGS model ranging from0.92 cm/yr
for a prediction of 6.4 cm/yr (the lowest KIGS prediction in
our validation group) to 1.2 cm/yr when 17.3 cm/yr was
predicted (highest predicted value). Corrections for predic-
tions of in-between values will be smaller, and for a predicted
HV of 11.2 cm/yr the correction term is zero.
The validation performed on the KIGS model as described
in the report by Ranke et al. (2), consisting of testing whether
there was a significant difference between observed and
predicted values, is only a check for a systematic prediction
error (overall too low or too high predictions) and will not
disclose overfitting.
In the Dutch cohort the sd of the prediction errors of the
calibrated model was higher than the published sd of 1.46
cm/yr of the prediction errors found in the KIGS cohort (2).
This was to be expected because a prediction model will be
less precise for new data than for the data on which it was
derived. Another important finding was the dependency ofFIG. 2. Prediction errors vs. predicted value of the calibrated model.
TABLE 2. Examples of predictions and 95% PIs using the KIGS model and using the calibrated model
Original KIGS model Calibrated model
Prediction (cm/yr) 95% PI Width of PI Prediction (cm/yr) 95% PI Width of PI
Example 1 7.0 4.1–9.9 5.7 7.8 5.4–10.2 4.8
Example 2 14.0 11.1–16.9 5.7 13.5 7.9–19.0 11.1
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variance of the prediction error on the magnitude of the
prediction. We found that the prediction error sd was rang-
ing from 1.07 cm/yr for a prediction of 7.3 cm/yr (our lowest
calibrated prediction) to 3.58 cm/yr when the predicted out-
come was 16.1 cm/yr (highest calibrated prediction). This
means that the accuracy of a high prediction of HV is less
than the accuracy of a low prediction, as reflected in the 95%
PI accompanying the predicted response.
When developing the KIGS model, the analysts also
checked for a relation between the variance of the prediction
error and the prediction, by plotting Studentized residuals
vs. predicted HV (2). In contrast to our findings, they did not
find a relation. We cannot explain the discrepancy between
their and our findings.
For calculation of the sd scores for the KIGS cohort, United
Kingdom reference data (9, 10) were used. Dutch children
and adults are known to be among the tallest on earth (20).
Moreover, the secular trend in The Netherlands is relatively
large (10, 16). If Dutch reference data were used, for parents
dated back one generation, the predictions were not much
different from the original predictions, but if we calculated
the sd scores ignoring the secular trend, the predictions were
significantly too low. In both situations the overfitting re-
mained. Thus, to apply the KIGS model correctly, one should
use the United Kingdom reference data.
The KIGS model is a well defined and easily applicable
model developed on a population of sufficient size. The
percentage of explained variability (r2 0.61) might improve
if more flexibility of the relations was allowed or other pa-
tient characteristics could be used, but the aim might have
been to restrict to simple modeling with widely available
characteristics. However, the problem of overfitting, which
is very likely to be present if model selection and estimation
are made using the same dataset, was not taken into account.
As a consequence of our calibration and of modeling the
dependency of the prediction error sd, we propose that a
KIGS prediction for the first year growth response in children
with IGHD should be modified using the formula:
Ycal Yorig 2.153 0.192  Yorig
where Ycal is the calibrated prediction, and Yorig is the orig-
inal KIGS prediction.
The 95% PI is given by:
Ylow Ycal 1.96  1.017 0.286  Ycal
Yhigh Ycal 1.96  1.017 0.286  Ycal
where again Ycal is the calibrated prediction, Ylow is the lower
limit of the PI, and Yhigh is the upper limit of the PI. Figure
4 presents the calibrated predictions vs. the original KIGS
predictions, with 95% PI. It shows that, for instance, an orig-
inal prediction of 14 cm/yr should be modified to 13.5 cm/
yr, with 95% PI of 8–19 cm/yr.
Our validation and calibration of the KIGS model are quite
different from developing a new model. In our calibrated
model we maintained the relative contributions of the pre-
dictor variables as determined for the original model, but the
outcomes were adjusted using a correction term that de-
pends on the value of the original prediction. Clearly these
FIG. 3. Examples of calibration plots of prediction models for which the predictions are perfect (A), unbiased (B), too high (C), and overfitted (D).
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calibrated predictions fitted better to the data of the Dutch
cohort. Whether both the data from the KIGS cohort, used for
modeling, as well as the data from the Dutch cohort, used for
calibration, are representative of other cohorts of children
with IGHD fulfilling the same in- and exclusion criteria is not
yet known. We, however, postulate that our modification of
the KIGS prediction rule will give better predictions for these
children as well.
When new prediction models are developed in the future,
they should be evaluated as to whether a calibration is re-
quired. The best way to examine this is by validation of the
model using external data. This will improve the accuracy
and benefit of prediction models for clinical practice.
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